Comparative Analysis of Traditional Chinese Medicine and Contemporary Treatments for Psoriasis Vulgaris

Lijiaming Zhou,1,2,* Zhengchun Wang,2,3,* Yan Wang,2,* Manning Wu,1,2 Yuemin Zou,1,2 Yueyue Ma,2,3 Wenbo Liu,2,3 Jingxia Zhao,1 Dongmei Zhou,2 Ping Li2 1Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Department of Dermatology, Clinical Medical School of Beijing University of Chinese Medicine (Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine), Beijing, People’s Republic of China; 3Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Dongmei Zhou, Email [email protected] Ping Li, Email [email protected]: This scoping review synthesizes existing research comparing traditional Chinese medicine (TCM) and contemporary treatments (CTs) for managing psoriasis vulgaris (PsV). A thorough literature search was conducted across multiple databases through February 2024, identifying relevant systematic reviews, randomized controlled trials (RCTs), quasi-experimental, and observational studies that contrast TCM approaches with CTs for PsV. From an initial pool, 195 articles were analyzed, indicating a growing interest in this comparative area, with most studies involving sample sizes between 30 and 100 participants. Key interventions included both internal and topical applications of Chinese herbal medicines, notably Rehmanniae Radix, Arnebiae Radix, and Smilacis Glabrae Rhizoma. Outcomes focused on PASI scores, quality of life metrics, and adverse effects. Results suggest that TCM offers efficacy in improving PASI scores and quality of life; however, evidence concerning toxicity profiles, recurrence rates, and comorbidity outcomes remains sparse. Notable research gaps include a lack of comprehensive data on newer treatment modalities, particularly biologics. Future studies should aim to delineate subjects and interventions in greater detail to support clinical applicability.Keywords: psoriasis vulgaris, traditional Chinese medicine, evidence map, clinical study, scoping review

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-10-01
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative Analysis of Traditional Chinese Medicine and Contemporary Treatments for Psoriasis Vulgaris

SHILAP Revista de lepidopterología
Psoriasis: Treatment and Pathogenesis
article

Comparative Analysis of Traditional Chinese Medicine and Contemporary Treatments for Psoriasis Vulgaris

article en

Abstract

Lijiaming Zhou,1,2,* Zhengchun Wang,2,3,* Yan Wang,2,* Manning Wu,1,2 Yuemin Zou,1,2 Yueyue Ma,2,3 Wenbo Liu,2,3 Jingxia Zhao,1 Dongmei Zhou,2 Ping Li2 1Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Department of Dermatology, Clinical Medical School of Beijing University of Chinese Medicine (Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine), Beijing, People’s Republic of China; 3Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Dongmei Zhou, Email [email protected] Ping Li, Email [email protected]: This scoping review synthesizes existing research comparing traditional Chinese medicine (TCM) and contemporary treatments (CTs) for managing psoriasis vulgaris (PsV). A thorough literature search was conducted across multiple databases through February 2024, identifying relevant systematic reviews, randomized controlled trials (RCTs), quasi-experimental, and observational studies that contrast TCM approaches with CTs for PsV. From an initial pool, 195 articles were analyzed, indicating a growing interest in this comparative area, with most studies involving sample sizes between 30 and 100 participants. Key interventions included both internal and topical applications of Chinese herbal medicines, notably Rehmanniae Radix, Arnebiae Radix, and Smilacis Glabrae Rhizoma. Outcomes focused on PASI scores, quality of life metrics, and adverse effects. Results suggest that TCM offers efficacy in improving PASI scores and quality of life; however, evidence concerning toxicity profiles, recurrence rates, and comorbidity outcomes remains sparse. Notable research gaps include a lack of comprehensive data on newer treatment modalities, particularly biologics. Future studies should aim to delineate subjects and interventions in greater detail to support clinical applicability.Keywords: psoriasis vulgaris, traditional Chinese medicine, evidence map, clinical study, scoping review

SHILAP Revista de lepidopterología
Openalex Percentile: Top 42%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.